Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Twist Bioscience Corp Director's Dealing 2021

Apr 26, 2021

31873_dirs_2021-04-26_473b0fea-f552-4e85-a8d4-613323a527a3.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Twist Bioscience Corp (TWST)
CIK: 0001581280
Period of Report: 2021-04-22

Reporting Person: THORBURN JAMES M (N/A)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-04-22 Common Stock M 5000 $11.59 Acquired 53034 Direct
2021-04-22 Common Stock S 5000 $133.47 Disposed 48034 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2021-04-22 Employee Stock Option (right to buy) $11.59 M 5000 Disposed 2028-06-06 Common Stock (5000) Direct

Footnotes

F1: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on December 16, 2020.

F2: The option is immediately exercisable. 25% of the shares subject to the option vested on April 23, 2019, and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.